article thumbnail

Top 20 RNAi Therapeutic Companies Based on 2022 R&D Expenditure

PharmaShots

This drug is currently in multiple P-IIa clinical trials and is being evaluated in combination with other antiviral agents for cHBV. Founded Year: 2018 Total Employees: ~80 Headquarters: California, United States Market Cap: $43.1M It is a subcutaneous RNAi therapeutic designed to reduce HBV viral antigens, including HBsAg.

article thumbnail

Agile, Data-Driven Life Cycle Management for Continuous Manufacturing

ISPE

1 , 4 A Retrospective Journey In 2015, Vertex’s Orkambi was the first approved drug produced under a CM process for the treatment of cystic fibrosis. Vertex continued to invest in CM with two additional approved drugs—Symdeco/Symkevi in 2018 and Trikafta in 2019—with the same indication. Published 24 September 2018. Garcia, D.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How Balancing Iron Levels Can Help Your Thyroid

The Thyroid Pharmacist

5] A 2018 study found that in women with persistent symptoms of hypothyroidism despite levothyroxine therapy, two-thirds were able to eliminate their symptoms when they got their ferritin levels over 100 µg/l. [6] And as we’ve seen, even with supplementation, you need to address your root causes to prevent iron supply and demand challenges.

article thumbnail

How Do Adaptogenic Herbs Benefit Hashimoto’s?

The Thyroid Pharmacist

Nikolai Lazarev defined adaptogens as “an agent that raises the body’s ability to resist stress by countering undesired stressors, whether physical, chemical, emotional, or biological.” Would you like to know if adaptogenic herbs might be of benefit to you? This can also mean fewer nutrients are absorbed.